Nemes Rush Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Sell
89,225
-7,231
-7% -$1.68M 2.07% 11
2025
Q4
$20M Buy
96,456
+1,327
+1% +$262K 1.88% 12
2025
Q3
$17.6M Buy
95,129
+1,399
+1% +$240K 1.75% 17
2025
Q2
$14.3M Buy
93,730
+31,851
+51% +$4.9M 1.56% 21
2025
Q1
$10.3M Buy
61,879
+5,925
+11% +$927K 1.3% 28
2024
Q4
$8.09M Buy
55,954
+7,114
+15% +$1.1M 1% 32
2024
Q3
$7.73M Sell
48,840
-2,429
-5% -$387K 1.12% 32
2024
Q2
$7.49M Buy
51,269
+2,171
+4% +$323K 1.03% 35
2024
Q1
$7.77M Sell
49,098
-5,043
-9% -$803K 1.11% 32
2023
Q4
$8.49M Sell
54,141
-4,039
-7% -$619K 1.37% 25
2023
Q3
$9.06M Buy
58,180
+1,833
+3% +$302K 1.64% 19
2023
Q2
$9.33M Buy
+56,347
New +$9.09M 1.64% 20

Other funds holding JNJ

Nemes Rush Group's JNJ Position: Q1 2026 in Review

Nemes Rush Group reduced its Johnson & Johnson (JNJ) stake by 7.5% in Q1 2026, selling an estimated $1.68M and leaving 89,225 shares worth $21.8M. The position accounts for 2.07% of the portfolio, ranked #11.

Nemes Rush Group first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Nemes Rush Group held 89,225 shares of Johnson & Johnson worth $21.8M as of Q1 2026.
  • Nemes Rush Group sold 7,231 Johnson & Johnson shares in Q1 2026, an estimated $1.68M.
  • Johnson & Johnson made up 2.07% of Nemes Rush Group's portfolio in Q1 2026, its #11 holding.
  • Nemes Rush Group first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.